Cuchillo, C.M.; Parés, X.; de Llorens, R.; Nogués, M.V. (editors) "Proceedings of the 2nd International Meeting on Structure, Mechanism and Function of Ribonucleases." Publicacions Universitat Autònoma de Barcelona 1 (1991): 1-300.
Barrabés, S.; Llop, E.; Ferrer-Batallé, M.; Ramírez, M.; Aleixandre, R.N.; Perry, A.S.; de Llorens, R.; Peracaula, R. "Analysis of urinary PSA glycosylation is not indicative of high-risk prostate cancer." Clinica Chimica Acta 470 (2017): 97-102. Ferrer-Batallé M; Llop E; Ramírez M; Aleixandre RN; Saez M; Comet J; De Llorens R; Peracaula R "Comparative study of blood-based biomarkers, α2,3-sialic acid PSA and PHI, for high risk prostate cancer detection." International Journal of Molecular Sciences 18 (2017): 845-. Barrabés, S.; Farina-Gomez, N.; Llop, E.; Puerta, A.; Diez-Masa, J.C.; Perry, A.; de Llorens, R.; de Frutos, M.; Peracaula, R. "Comparative analysis of prostate-specific antigen by two-dimensional gel electrophoresis and capillary electrophoresis." Electrophoresis 38 (2017): 408-416. Martínez MÁ, Carranza MP, Massaguer A, Santos L, Organero JA, Aliende C, de Llorens R, Ng-Choi I, Feliu L, Planas M, Rodríguez AM, Manzano BR, Espino G, Jalón FA "Synthesis and Biological Evaluation of Ru(II) and Pt(II) Complexes Bearing Carboxyl Groups as Potential Anticancer Targeted Drugs.." Inorganic Chemistry (2017): -. Queralt B; Cuyàs E; Bosch-Barrera J; Massaguer A; De Llorens R; Martin-Castillo B; Brunet J; Salazar R; Menendez JA. "Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer." Oncotarget 7 (2016): 82185-82199. Llop, E.; Ferrer-Batallé, M.; Barrabés, S.; Guerrero, P.E.; Ramírez, M.; Saldova, R.; Rudd, P.M.; Aleixandre, R.N.; Comet, J.; de Llorens, R.; Peracaula, R. "Improvement of Prostate Cancer diagnosis by detecting PSA glycosylation-specific changes." Theranostics 6 (2016): 1190-1204. Ferri MJ; Saez M; Figueras J; Fort E; Sabat M; López-Ben S; De Llorens R; Aleixandre RN; Peracaula R "Improved pancreatic adenocarcinoma diagnosis in jaundiced and non-jaundiced pancreatic adenocarcinoma patients through the combination of routine clinical markers associated to pancreatic adenocarcinoma pathophysiology." PLoS One 11 (2016): e0147214.-. Panosa C, Fonge H, Tebar F, Ferrer-Batallé M, Massaguer A, De Llorens R and Reilly RM "Targeted delivery of 111 In to EGFR positive Breast Cancer Cells using an EGF derivative." Nuclear Medicine and Biology (2015): -. Cuyàs, E; Fernández-Arroyo, S; Corominas-Faja, B; Rodríguez-Gallego, E; Bosch-Barrera, J; Martin-Castillo, B; De Llorens, R; Joven, J; Menendez, J.A "Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype." Oncotarget 6 (2015): 12279-12296. Meritxell Balmaña; Ariadna Sarrats; Esther Llop; Sílvia Barrabés; Radka Saldova; Maria-José Ferri; Joan Figueras; Esther Fort; Rafael de Llorens; Pauline M Rudd; Rosa Peracaula "Identification of potential pancreatic cancer serum markers: increased sialyl-Lewis X on ceruloplasmin." Clinica Chimica Acta 442 (2015): 56-62. Pérez-Garay M; Arteta B; Llop E; Cobler L; Pagès L; Ortiz R; Ferri MJ; de Bolós C; Figueras J; de Llorens R; Vidal-Vanaclocha F; Peracaula R. "α2,3-Sialyltransferase ST3Gal IV promotes migration and metastasis in pancreatic adenocarcinoma cells and tends to be highly expressed in pancreatic adenocarcinoma tissues." The International Journal of Biochemistry and Cell Biology 45 (2013): 1748-1757. Panosa C; Tebar F; Ferrer-Batallé M; Fonge H; Seno M; Reilly RM; Massaguer A; De Llorens R. "Development of an epidermal growth factor derivative with EGFR blocking activity." PLoS One 8 (2013): e69325-. Sekhar SC, Kasai T, Satoh A, Shigehiro T, Mizutani A, Murakami H, El-Aarag B, Salomon DS, Massaguer A, de Llorens R, Seno M. "“Identification of Caveolin-1 as a Potential Causative Factor in the Generation of Trastuzumab Resistance in Breast Cancer Cells. ." Journal Of Cancer 4 (2013): 391-401. Aliende, C.; Pérez-Manrique, M.; Jalón, F.A.; Manzano, B.R.; Rodríguez, A.M.; Cuevas, J.V.; Espino, G.; Martinez, M.A.; Massaguer, A.; González-Bártulos, M.; LLorens, R.; Moreno, V. "Preparation of new half sandwich ruthenium arene complexes with aminophosphines as potential chemotherapeutics." Journal of Inorganic Biochemistry 117 (2012): 171-188. Barragán, Flavia ; Carrion Salip, Dolors ; Gómez-Pinto, Irene ; González-Cantó, Alejandro ; Sadler, Peter J. ; Llorens Duran, Rafael de ; Moreno, Virtudes ; González Ibañez, Carlos ; Massaguer i Vall-llovera, Anna ; Marchán, "Somatostatin subtype 2 receptor-targeted metal-based anticancer complexes." Bioconjugate Chemistry 23 (2012): 1838-1855. Carrion-Salip D; Panosa C; Menendez JA; Puig T; Oliveras G; Pandiella A; Llorens R; Massaguer A "Androgen-independent prostate cancer cells circumvent EGFR inhibition by overexpression of alternative HER receptors and ligands." International Journal of Oncology 41 (2012): 1128-1138. Oliveras-Ferraros C, Cufí S, Queralt B, Vazquez-Martin A, Martin-Castillo B, de Llorens R, Bosch-Barrera J, Brunet J, Menéndez JA. "Cross-suppression of EGFR ligands amphiregulin and Epiregulin and de-repression of FGFR3 signaling contribute to cetuximab resistance in wild-type KRAS tumour cells ." British Journal of Cancer 106 (2012): 1406-1414. Oliveras –Ferraros C, Massaguer A, Vazquez-Martín A, Carrion-Salip D, Quera lt B, Cufí S, Martin -Casti llo B, Bosch –Barrera J, Brunet J, de Llorens R, Menendez JA "Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment." Oncology Reports 27 (2012): 1887-1892. Oliveras-Ferraros, Cristina; Massaguer Vall-llovera, Anna; Carrion Salip, Dolors; Vazquez-Martin, Alejandro; Cufí, Silvia; Queralt, Bernardo; Martin-Castillo, Begoña; Brunet, Joan; Llorens, Rafael de; Menéndez, Javier A. "Evolution of the predictive markers amphiregulin and epiregulin mRNAs during long-term cetuximab treatment of KRAS wild-type tumor cells." Investigational New Drugs 30 (2012): 846-852. Oliveras-Ferraros C, Vazquez-Martin A, Queralt B, Adrados M, Ortiz R, Cufí S, Hernández-Yagüe X, Guardeño R, Báez L, Martin-Castillo B, Pérez-Martínez MC, Lopez-Bonet E, De Llorens R, Bernadó L, Brunet J, Menendez JA. "Interferon / STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models'.." International Journal of Oncology 6 (2011): 1455-1479. Barrabés, S.; Sarrats, A.; Fort, E.; Rudd, P.M.; Llorens, R.; Peracaula, R. "Effect of sialic acid content on glycoprotein pI analyzed by two-dimensional electrophoresis." Electrophoresis 31 (2010): 2903-2912. Sarrats, A.; Comet, J.; Tabarés, G.; Ramirez, M.; Aleixandre, R.N.; Llorens, R.; Peracaula, R. "Differential percentage of serum prostate-specific antigen subforms suggests a new way to improve prostate cancer diagnosis ." Prostate 70 (2010): 1-9. Pérez,M.;Arteta,B.;Pagès, Ll.;de Llorens, R.;de Bolós, C.;Vidal-Vanaclocha, F.;Peracaula, R. "Alpha2,3-Sialyltransferase ST3Gal III Modulates Pancreatic Cancer Cell Motility and Adhesion In Vitro and Enhances Its Metastatic Potential In Vivo." PLoS One 5 (2010): e12524-. SARRATS, A., SALDOVA, R., PLA, E., FORT, E., HARVEY, DJ., STRUWE, WB., DE LLORENS, R., RUDD, PM., PERACAULA, R. "Glycosylation of the liver acute-phase proteins in pancreatic cancer and chronic pancreatitis." Proteomics. Clinical applications 4 (2010): 432-448. SARRATS, A., SALDOVA, R., COMET, J., O'DONOGHUE, N., DE LLORENS, R., RUDD, PM., PERACAULA, R. "Glycan characterization of total PSA 2 DE subforms from serum and seminal plasma." Omics-a Journal Of Integrative Biology 4 (2010): 465-474. Parajó, Y.; Arolas, J.L.; Moreno, V.; Sánchez-onzález, A.; Sordo, J.; Llorens, R.; Avilés, F.X.; Lorenzo, J. "Cytotoxicity studies of [PtCl2(H2bim)] (H2bim = 2,2′-biimidazole): Study of its interaction with a small protein PCI (potato carboxypeptidase inhibitor." Inorganica Chimica Acta 362 (2009): 946-952. Peracaula, R.; Barrabés, S.; Sarrats, A.; Rudd, P.M.; Llorens, R. "Altered glycosylation in tumours focused to cancer diagnosis." Disease Markers 25 (2008): 207-218. Martinez, A.; Moreno, V.; Sanglas, L.; De Llorens, R.; Avilés, F.X.; Lorenzo, J. "Study by HPLC-MS of the interaction of platinum antitumor complexes with potato carboxypeptidase inhibitor (PCI)." Bioorganic and Medicinal Chemistry 16 (2008): 6832-6840. Oliveras-Ferraros, C.; Vázquez-Martín, A.; Colomer, R.; Llorens, R.; Brunet, J.; Menendez, J.A. "Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: The importance of scheduling." International Journal of Oncology 32 (2008): 113-120. Barrabés, S.; Pages, L.; Radcliffe, C.M.; Tabares, G.; Fort, E.; Royle, L.; Harvey, D.J.; Moenner, M.; Dwek, R.A.; Rudd, P.M.; Llorens, R.; Peracaula, R. "Glycosylation of serum ribonuclease 1 indicates a major endothelial origin and reveals an increase in core fucosylation in pancreatic cancer." Glycobiology 17 (2007): 388-400. Ferrer, L.; Vázquez, A.; Brunet, J.; Llorens, R.; Colomer, R. "An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: gefitinib (Iressatrade mark)-induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review)." International Journal of Molecular Medicine 20 (2007): 3-10. Tabarés, G.; Jung, K.; Reiche, J.; Stephan, C.; Lein, M.; Peracaula, R.; Llorens, R.; Hösel, W. "Free PSA forms in prostatic tissue and sera of prostate cancer patients: analysis by 2-DE and western blotting of immunopurified samples." Clinical Biochemistry 40 (2007): 343-350. Tabarés, G.; Radcliffe, C.; Barrabés, S.; Ramírez, M.; Aleixandre, R.N.; Hoesel, W.; Dwek, R.; Rudd, P.; Peracaula, R.; Llorens, R. "Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA." Glycobiology 16 (2006): 132-145. Sitjà, M.; Molina, M.A.; Blanco, C.; Ferrer, L.; Lorenzo, J.; Avilés, F.X.; Querol, E.; Llorens, R. "Mechanism of action of potato Carboxypeptidase Inhibitor (PCI) as an EGF blocker." Cancer Letters 226 (2005): 169-184. Peracaula, R.; Tabarés, G.; López-Ferrer, A.; Brossmer, R.; Bolós, C.; Llorens, R. "Role of sialyltransferases involved in the biosynthesis of Lewis antigens in human pancreatic tumour cells ." Glycoconjugate Journal 22 (2005): 135-144. Martinez, A.; Lorenzo, J.; Prieto, M.J.; Llorens, R.; Font, M.; Solans, X.; Avilés, F.X.; Moreno, V. "Synthesis, characterization and biological activity of trans-platinum (II) and trans-platinum (IV) complexes with 4-hydroxymethylpyridine ." ChemBioChem 6 (2005): 2068-2077. Gay, M.; Montana, A.M.; Moreno, V.; Prieto, M.J.; Llorens, R.; Ferrer, L. "Studies of interaction of dichloro [eta(2)-dimethyl-(2-methylidene-cyclohexylmethyl)-amino] platinum (II) with DNA: effects on secondary and tertiary structures of DNA. Cytotoxic assays on human cancer cell lines Capan-1 and A431 ." Journal of Inorganic Biochemistry 99 (2005): 2387-2394. Moradell, S.; Lorenzo, J.; Rovira, A.; van Zutphen, S.; Avilés, F.X.; Moreno, V.; Llorens, R.; Martinez, J.; Reedijk, J.; Llobet, A. "Water-soluble platinum(II) complexes of diamine chelating ligands bearing amino-acid type substituents: the effect of the linked amino acid and the diamine chelate ring size on antitumor activity, and interactions with 5'-GMP and DNA." Journal of Inorganic Biochemistry 11 (2004): 1933-1946. Castella, S.; Benedetti, H.; Llorens, R.; Dacheux, F.; Dacheux, J.L. "Functionalities and regulation of an epididymal-specific RNase-A like (Train A)." Biology of Reproduction 5 (2004): 1677-1687. Peracaula, R.; Tabarés, G.; Royle, L.; Harvey, D.; Dwek, R.; Rudd, P.; Llorens, R. "Altered glycosylation pattern allows the distinction between Prostate Spedific Antigen (PSA) from normal and tumour origins." Glycobiology 13 (2003): 457-470. Peracaula, R.; Royle, L.; Tabarés, G.; Mallorquí-Fernández, G.; Barrabés, S.; Harvey, D.; Dwek, R.; Rudd, P.; Llorens, R. "Glycosylation of human pancreatic ribonuclease: differences between normal and tumor states." Glycobiology 13 (2003): 227-244. Ferrer-Soler, L.; Cedano, J.; Querol, E.; Llorens, R. "Cloning, expression and purification of human epidermal growth factor using different expression systems." Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 788 (2003): 113-123. Moradell, S.; Lorenzo, J.; Rovira, A.; Robillard, M.S.; Avilés, F.X.; Moreno, V.; Llorens, R.; Martinez-Lorente, M.A.; Reedijk, J.; Llobet, A. "Platinum complexes of diaminocarboxylic acids and their ethyl ester derivatives: the effect of the chelate ring size on antitumor activity and interactions with GMP and DNA ." Journal of Inorganic Biochemistry 96 (2003): 493-502. Maeda, T.; Kitazoe, M.; Murato, Y.; Tada, H.; Ueda, M.; Llorens, R.; Salomon, D.S.; Yamada, H.; Seno M. "Growth inhibition of mammalian cells by eosinophil cationic protein ." European Journal of Biochemistry 269 (2002): 307-316. López-Torrejón, I.; Querol, E.; Avilés, A.; Seno, M.; Llorens, R.; Oliva, B. "Human betacellulin structure modelled from other members of EGF family." Journal of Molecular Modeling 8 (2002): 131-144. Pous, J.; Mallorquí-Fernández, G.; Peracaula, R.; Terzyan, S.S.; Futami, J.; Tada, H.; Yamada, H.; Seno, M.; Llorens, R.; Gomis-Rüth, FX.; Coll, M. "Three-dimensional structure of human RNase 1ΔN7 at 1.9 Å resolution ." Acta Crystallographica Section D-Biological Crystallography 57 (2001): 498-505. Mas, J.M.; Aloy, P.; Martí-Renom, M.; Oliva, B.; Llorens, R.; Avilés, F.X. Querol, E. "Protein classification based on the disulphide bridges topology." Journal of Computer-Aided Molecular Design 15 (2001): 477-487. Peracaula, R.; Cleary, K.R.; Lorenzo, J.; Llorens, R.; Frazier, M.L. "Human pancreatic ribonuclease 1: expression and distribution in pancreatic adenocarcinoma." Cancer 89 (2000): 1252-1258. Fernández-Salas, E.; Peracaula, R.; Frazier, M.L.; Llorens, R. "Ribonucleases expressed by human pancreatic adenocarcinoma cell lines." European Journal of Biochemistry 267 (2000): 1484-1494. Mallorquí-Fernández, G.; Pous, J.; Peracaula, R.; Aymami, J.; Maeda, T.; Tada, H.; Yamada, H.; Seno, M.; Llorens, R.; Gomis-Rüth, FX.; Coll, M. "Three-dimensional crystal structure of human eosinophil cationic protein (RNase 3) at 1.75 A resolution." Journal of Molecular Biology 300 (2000): 1297-1307. TERZYAN, S. S., PERACAULA, R., de LLORENS, R., TSUSHIMA, Y., YAMADA, H., SENO, M., GOMIS-RÜTH, X. y COLL, M. "The Three Dimensional Structure of Human RNase 4, Unliganded and Complexed with d(Up), Reveals the Bases for its Uridine Selectivity. ." Journal of Molecular Biology 285 (1999): 205-214. MAS, J., ALOY, P., MARTÍ-RENOM, M.A., OLIVA, B., MOLINA, M. A., de LLORENS, R., QUEROL, E. y AVILÉS, F. X. "Protein Similarities Beyond Didulphide Bridge Topology.." Journal of Molecular Biology 284 (1998): 541-548. BLANCO-APARICIO, C., MOLINA, M. A., FERNÁNDEZ-SALAS, E., FRAZIER, M. L., MAS, J., QUEROL, E., AVILÉS, F. X. y de LLORENS, R "Potato Carboxypeptidase Inhibitor, a T-knot Protein, Is an Epidermal Growth Factor Antagonist That Inhibits Tumor Cell Growth.." Journal of Biological Chemistry 273 (1998): 12370-12377. RIBÓ, M., delCARDAYRÉ, S. B., RAINES, R. T., de LLORENS, R. y CUCHILLO, C. M. "Production of human pancreatic ribonuclease in Saccharomyces cerevisiae and Escherichia coli. ." Protein Expression and Purification 7 (1996): 253-261. FRAZIER, M. L., FERNÁNDEZ, E., de LLORENS, R., BROWN, N. M., PATHAK, S., CLEARY, K. R., ABBRUZZESE, J. L., BERRY, K., OLIVÉ, M., Le MAISTRE, A. y EVANS, D. B. "Pancreatic Adenocarcinoma Cell Line, MDAPanc-28, with Features of Both Acinar and Ductal Cells. ." International Journal of Pancreatology 19 (1996): 31-38. BRAVO, J., FERNÁNDEZ, E., RIBÓ, M., de LLORENS, R. y CUCHILLO, C.M. "A Versatile Negative-Staining Ribonuclease Zymogram.." Analytical Biochemistry 218 (1994): 82-86. FONTECILLA-CAMPS, J. C., de LLORENS, R., M. H. Le DU y CUCHILLO, C.M. "Crystal Structure of Ribonuclease A.d(ApTpApApG) Complex. Direct Evidence for extended substrate recognition. ." Journal of Biological Chemistry 269 (1994): 21526-21531. Ribó, M., Beintema, J. J., Osset, M., Fernández, E., Bravo, J., Llorens, R. and Cuchillo C. M. "Heterogeneity in the Glycosylation Pattern of Human Pancreatic Ribonuclease. ." Biological Chemistry Hoppe-Seyler 375 (1994): 357-363. FERNÁNDEZ, E., FALLON, M. J. M., FRAZIER, M. L., de LLORENS, R. y CUCHILLO, CM "Expression of Acinar and Ductal Products in Capan-1 Cells Growing in Synthetic Serum and Serum-Free Media. ." Cancer 73 (1994): 2285-2295. PARÉS, X., NOGUÉS, M. V., de LLORENS, R. y CUCHILLO, C.M. "Structure and Function of Ribonuclease A Binding Subsites.." Essays in Biochemistry 26 (1991): 89-103. OSSET, M. PIÑOL, M., FALLON, M. J. M., de LLORENS, R. y CUCHILLO, C.M. "Interference of the carbohydrate moiety in Coomassie Brilliant Blue R-250 protein staining. ." Electrophoresis 10 (1989): 271-273. De LLORENS, R., ARÚS, C., PARÉS, X. y CUCHILLO, C.M. "Chemical and computer graphics studies on the topography of the ribonuclease A active site cleft. A model of the enzyme-pentanucleotide substrate complex. ." Protein Engineering 2 (1989): 417-429. OSSET, M. PIÑOL, M., FALLON, M. J. M., de LLORENS, R. y CUCHILLO, C.M. "Bovine pancreatic ribonuclease: studies of the sugar moiety composition by means of gas-liquid chromatography and a lectin-binding assay. ." Life Sciences Advances 7 (1988): 327-332. RICHARDSON, R. M., PARÉS, X., LLORENS, R., NOGUÉS, M. V. y CUCHILLO,C.M. "Nucleotide binding and affinity labelling support the existence of the phosphate-binding Subsite P2 in bovine pancreatic ribonuclease A. ." Biochimica et Biophysica Acta. General Subjects 953 (1988): 70-78. De LLORENS, R. y CUCHILLO, C.M. "La ribonucleasa como marcador del cáncer de páncreas. ." Neoplasia 3 (1986): 80-87. De LLORENS, R., PIÑOL, M., OSSET, M. y CUCHILLO, C.M. "Estudio de los isozimas de la ribonucleasa como posibles marcadores tumorales.." Revisiones sobre Biología Celular S3 (1986): 173-178. De LLORENS, R. y CUCHILLO, C.M. "Diseño de nuevos fármacos por ordenador. II ." El Farmacéutico 21 (1986): 35-38. De LLORENS, R. y CUCHILLO, C.M. "Diseño de nuevos fármacos por ordenador. ." El Farmacéutico 20 (1985): 53-57. ARÚS, C., PAOLILLO, L., LLORENS, R., NAPOLITANO, R. y CUCHILLO, C.M. "Evidence on the existence of a purine ligand induced conformational change in the active site of bovine pancreatic ribonuclease A studied by proton nuclear magnetic resonance spectroscopy. ." Biochemistry 21 (1982): 4290-4297. ARÚS, C., PAOLILLO, L., LLORENS, R., NAPOLITANO, R., PARÉS, X. y CUCHILLO,C.M. "1H-NMR Studies on the binding subsites of bovine pancreatic ribonuclease A. ." Biochimica et Biophysica Acta. General Subjects 680 (1981): 117-127. PARÉS, X., LLORENS, R., ARÚS, C. y CUCHILLO, C.M. "The reaction of bovine pancreatic ribonuclease A with 6-chloropurineriboside 5’-monophosphate. Evidence on the existence of a Phosphate-Binding sub-site. ." FEBS Journal, abans European J. of Biochemistry 105 (1980): 571-579. PARÉS, X., ARÚS, C, LLORENS, R. y CUCHILLO, C.M. "The specificity of the interaction of bovine pancreatic ribonuclease A with natural and halogenated purine nucleotides.." Biochemical Journal 175 (1978): 21-27.